Your browser doesn't support javascript.
loading
Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects.
Wang, Zhang; Saha, Somdutta; Van Horn, Stephanie; Thomas, Elizabeth; Traini, Christopher; Sathe, Ganesh; Rajpal, Deepak K; Brown, James R.
Afiliação
  • Wang Z; Computational Biology Target Sciences GlaxoSmithKline Research and Development (R&D) Collegeville PA USA.
  • Saha S; Computational Biology Target Sciences GlaxoSmithKline Research and Development (R&D) Collegeville PA USA.
  • Van Horn S; Present address: Solid Biosciences Cambridge MA USA.
  • Thomas E; Target and Pathway Validation Target Sciences GlaxoSmithKline R&D Collegeville PA USA.
  • Traini C; Target and Pathway Validation Target Sciences GlaxoSmithKline R&D Collegeville PA USA.
  • Sathe G; Target and Pathway Validation Target Sciences GlaxoSmithKline R&D Collegeville PA USA.
  • Rajpal DK; Target and Pathway Validation Target Sciences GlaxoSmithKline R&D Collegeville PA USA.
  • Brown JR; Computational Biology Target Sciences GlaxoSmithKline Research and Development (R&D) Collegeville PA USA.
Endocrinol Diabetes Metab ; 1(1): e00009, 2018 Jan.
Article em En | MEDLINE | ID: mdl-30815546
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article